Skip Ribbon Commands
Skip to main content
CIBMTR

Advisory Committee

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   |   About CIBMTR   |   Who We Are   |   Committees   |   Administrative Leadership Committees   |   Advisory Committee
  • Print
  • Share

Advisory Committee

The Advisory Committee is a worldwide group that reviews and approves CIBMTR activities.

Responsibilities

  • Oversee all scientific activities of the CIBMTR
  • Review policies of the organization including use of CIBMTR data
  • Review progress of ongoing studies including publications reports
  • Approval of elected individuals for positions on the Advisory, Executive, Nominating, CIDR Executive, and Clinical Trials Advisory Committees
  • Selects Distinguished Service Award recipient for BMT Tandem Meetings

Membership

  • Members to represent transplant centers in North America, Central and South America, Europe and Asia / Australia / Africa contingencies are elected by the CIBMTR Assembly for three-year terms
  • Members to represent patients, CIDR representative, and individuals with expertise in business and ethics are appointed by the Advisory Committee
  • Ex-officio members also represent the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), the National Institute for Allergy and Infectious Diseases (NIAID) and the Health Resources and Services Administration (HRSA), Office of Naval Research (ONR) and CIBMTR leadership
  • Members to represent donor centers and collection centers are appointment by CIBMTR Executive Director

Meetings

In-person Advisory Committee meetings are conducted once annually during the TCT Meetings. Meetings are open to the public and to federal representatives, except on rare occasions when deliberations pose a conflict of interest (such as in center confidentiality). Ad hoc task forces meet by teleconference as needed to address specific issues.

Elected Members
​Chair:
John Wingard, MD, Shands HealthCare & University of Florida, Gainesville, FL
Immediate Past Chair: Rob Soiffer, MD, Dana Farber Cancer Institute, Boston, MA
Vice Chairs:
  North America: Marcos de Lima, MD, Seidman Cancer Center-University Hospitals Cleveland Medical Center, Cleveland, OH
  Europe: Katarina Le Blanc, MD, PhD, Karolinska University Hospital, Centre for Allogeneic Stem Cell Transplantation, Stockholm, Sweden
  Central / South America: Gregorio Jaimovich, MD, Sanatorio Anchorena, Caba, Argentina and Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
  Asia / Africa / Australia: Biju George, MBBS, MD, Christian Medical College Hospital, Vellore, India
Members at Large:
​ ​ ​Edwin Alyea, MD, Duke Cancer Institute, Durham, NC
​ ​ Michael Bishop, MD, University of Chicago Medicine, Chicago, IL
​​​Claudio Brunstein, MD, PhD, University of Minnesota Blood and Marrow Transplant Program, Minneapolis, MN
    Heather Landau, MD, Memorial Sloan Kettering Cancer Center, New York, NY
    Steven Pavletic, MD, MS, NIH-NCI Experimental Transplantation and Immunology Branch, Bethesda, MD
​ ​ ​Bart Scott, MD, Fred Hutchinson Cancer Research Center, Seattle, WA
Non-North America: Mahmoud Aljurf, MD, MPH, King Faisal Specialist Hospital & Research Center, Riyadh, Soudi Arabia
​ ​ ​Carmem Sales Bonfim, MD, PhD, Hospital de Clinicas - UFPR, Curitiba, Brazil
    Shahrukh Hashmi, MD, MPH, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
​​​Steven Marsh, BSc, PhD, ARCS, Anthony Nolan Research Institute, London, England
​ ​ ​Tracey O'Brien, MBA, LLM, MBCHB, BSc, Sydney Children's Hospital, Sydney, Australia
​ ​ ​Anna Sureda, MD, PhD, Institut Catala d'Oncologia-Hospital Duran I Reynals, Barcelona, Spain

Appointed Members
​Bioethicist:
 Gregory Abel, MD, MPH, Dana Farber Cancer Institute, Boston, MA
​Business Representative: Jeff Chell, MD, NMDP/Be The Match, Minneapolis, MN
​CIDR Executive Committee Representative:
​Miguel-Angel Perales, MD, Memorial Sloan Kettering Cancer Center, New York, NY
​Collection Center Representative: James Mason, MD, Scripps Blood and Marrow Transplant Program, La Jolla, CA
​Cord Blood Bank Representative: Andromachi Scaradavou, MD, New York Blood Center, Long Island City, NY
​Donor Center Representative: Susan Rossmann, MD, PhD, Gulf Coast Marrow Donor Center, Houston, TX

Patient / Family Representatives
(Co-Chairs, Consumer Advocacy Committee):

Jack Aiello, EE, MS, San Jose, CA

Bryce Waldman, Chicago, IL

 

Ex Officio Voting Committee Members
​ASTCT Representative:
Pavan Reddy, MD
Be The Match / Navy Project Officer:TBD
MCW / NCI Project Officer:Lori Henderson, PhD
MCW / NHLBI Project Officers:

Nancy DiFronzo, PhD
Nahed El Kassar, MD, PhD

MCW / NIAID Project Officer:Linda Griffith, MD, PhD
Nominating Committee Chair (chair will not vote on Nominating Committee tasks):​Michael Verneris, MD

 

Ex Officio Non-Voting Committee Members
Chief Executive Officer, NMDP/Be The Match:
 Amy Ronneberg, NMDP/Be The Match, Minneapolis, MN
Chief Scientific Director: Mary M. Horowitz, MD, MS, CIBMTR, Milwaukee, WI
Chief Statistical Director: Mei-Jie Zhang, PhD, CIBMTR, Milwaukee, WI
Chief Medical Officer, NMDP/Be The Match; Associate Scientific Director / Senior Vice President of Research, CIBMTR Minneapolis:
​Steven Devine, MD, CIBMTR, Minneapolis, MN
​Associate Chief Scientific Director:
​Bronwen Shaw, MD, PhD, CIBMTR, Milwaukee, WI

Interim ​Senior Vice President, Patient Outcomes and Experience CIBMTR Minneapolis:

​​Mary Hengen, MBA, CIBMTR, Minneapolis, MN
Senior Scientific Director, SCTOD: J. Douglas Rizzo, MD, MS, CIBMTR, Milwaukee, WI

​Vice President, CIBMTR Minneapolis:

 ​TBD
Executive Director, CIBMTR Milwaukee: Patricia Steinert, PhD, MBA, CIBMTR, Milwaukee, WI​
Senior Manager, Data and Program Evaluation, Patient Services:
 Meggan McCann, MPH, Be The Match, Minneapolis, MN
Senior Research Advisor:
 Daniel Weisdorf, MD, CIBMTR, Minneapolis, MN
​Be The Match / MCW / HRSA Contracting Officer:
​Nawraz Shawir, MBBS
​MCW / HRSA Contracting Officers:
​TBD
Marilyn Levi, MD


Related Links:
Last Updated: 8/25/2020 2:30 PM
CIBMTR